🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
52-week, open-label extension study of double-blind study ACP-103-069 to de...
Status
Terminated
Location
Southwest Autism Research and Resource Center
Start Date
2022-11-02
Trial ID
NCT05555615
Treatments Being Tested
Schizophrenia is a severe, often chronic mental disorder, characterized by ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-12-01
Trial ID
NCT03994965
Treatments Being Tested
Patients with Parkinson's disease (PD) sometimes experience symptoms affect...
Status
Recruiting
Location
Southern Arizona VA Health Care System, Tucson, AZ
Start Date
2022-10-24
Trial ID
NCT04373317
Treatments Being Tested
This pilot, self-control study is for patients with Parkinson's Disease (PD...
Status
Withdrawn
Location
SUNY Downstate Health Sciences University
Start Date
2023-01-27
Trial ID
NCT05796167
Treatments Being Tested
An open-label, balanced, randomized, two treatment, two sequence, two perio...
Status
Completed
Location
Raptim Research Pvt. Ltd.,
Start Date
2024-01-11
Trial ID
NCT06450184
Treatments Being Tested
To evaluate the efficacy and safety of adjunctive pimavanserin compared wit...
Status
Completed
Location
Multiple Locations
Start Date
2016-10-26
Trial ID
NCT02970292
Treatments Being Tested
This Phase 2 study examines the safety, tolerability, and preliminary effic...
Status
Recruiting
Location
University of Kansas, Center for Research
Start Date
2025-10-01
Trial ID
NCT05999240
Treatments Being Tested
To evaluate the efficacy and safety of adjunctive pimavanserin compared wit...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-04
Trial ID
NCT02970305
Treatments Being Tested
This is a pilot study to explore the effects of pimavanserin and low-dose q...
Status
Terminated
Location
Movement Disorders Center of Arizona
Start Date
2019-10-23
Trial ID
NCT04164758
Treatments Being Tested
To evaluate the efficacy and safety of adjunctive pimavanserin compared wit...
Status
Completed
Location
603-Fundación para el Estudio y Tratamiento de las Enfermedades Mentales - FETEM
Start Date
2020-08-05
Trial ID
NCT04531982
Treatments Being Tested